Primary Immunodeficiency Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Efficacy, Safety and Pharmacokinetics Study of Kedrion IVIG 10% to Treat Participants With Primary Immunodeficiency (PID)
Condition: Primary Immunodeficiency Disease Intervention: Biological: Kedrion IVIG 10% Sponsor: Kedrion S.p.A. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2019 Category: Research Source Type: clinical trials
